S-EPMC6355471 - Efficacy of venetoclax monotherapy in patients with relapsed, refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor therapy. - OmicsDI

Unknown

Dataset Information

Efficacy of venetoclax monotherapy in patients with relapsed, refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor therapy.

ABSTRACT:

SUBMITTER: Eyre TA

PROVIDER: S-EPMC6355471 | biostudies-literature | 2019 Feb

REPOSITORIES: biostudies-literature